drugset / Trial / NCT06234514

Manage Macular Cystoid Edema With Retinal Vein Obstruction Using Traditional Chinese Medicine and Ranibizumab

NCT06234514

Phase 4 Completed 111 enrolled Dongyang People's Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study was to investigate the efficacy and safety of traditional Chinese medicine (Jueling Mingmu Decoction) combined with ranibizumab in the treatment of macular edema with retinal vein obstructive.

Timeline

Start
2023-01-01
Primary completion
2025-05-31
Completion
2025-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Jueling Mingmu decoction Traditional medicine (herbal / TCM) Oral
Subject Ranibizumab Monoclonal antibody 0.5 mg Intravitreal

Indications